Jason A Bartos1, Timothy R Matsuura2, Mohammad Sarraf1, Scott T Youngquist3, Scott H McKnite1, Jennifer N Rees1, Daniel T Sloper1, Frank S Bates4, Nicolas Segal1, Guillaume Debaty5, Keith G Lurie1, Robert W Neumar6, Joseph M Metzger2, Matthias L Riess7, Demetris Yannopoulos8. 1. Department of Medicine-Cardiovascular Division, University of Minnesota, United States. 2. Department of Integrative Biology and Physiology, University of Minnesota, United States. 3. Department of Emergency of Medicine, University of Utah, United States. 4. Department of Chemical Engineering and Materials Science, University of Minnesota, United States. 5. Department of Medicine-Cardiovascular Division, University of Minnesota, United States; UJF-Grenoble 1/CNRS/CHU de Grenoble/TIMC-IMAG UMR 5525, Grenoble F-38041, France. 6. Department of Emergency Medicine, University of Michigan, United States. 7. Department of Anesthesiology, TVHS VA Medical Center, Nashville, TN, United States; Department of Anesthesiology, Vanderbilt University, Nashville, TN, United States. 8. Department of Medicine-Cardiovascular Division, University of Minnesota, United States. Electronic address: yanno001@umn.edu.
Abstract
OBJECTIVE: Ischemic postconditioning (stutter CPR) and sevoflurane have been shown to mitigate the effects of reperfusion injury in cardiac tissue after 15min of ventricular fibrillation (VF) cardiac arrest. Poloxamer 188 (P188) has also proven beneficial to neuronal and cardiac tissue during reperfusion injury in human and animal models. We hypothesized that the use of stutter CPR, sevoflurane, and P188 combined with standard advanced life support would improve post-resuscitation cardiac and neurologic function after prolonged VF arrest. METHODS: Following 17min of untreated VF, 20 pigs were randomized to Control treatment with active compression/decompression (ACD) CPR and impedance threshold device (ITD) (n=8) or Bundle therapy with stutter ACD CPR+ITD+sevoflurane+P188 (n=12). Epinephrine and post-resuscitation hypothermia were given in both groups per standard protocol. Animals that achieved return of spontaneous circulation (ROSC) were evaluated with echocardiography, biomarkers, and a blinded neurologic assessment with a cerebral performance category score. RESULTS: Bundle therapy improved hemodynamics during resuscitation, reduced need for epinephrine and repeated defibrillation, reduced biomarkers of cardiac injury and end-organ dysfunction, and increased left ventricular ejection fraction compared to Controls. Bundle therapy also improved rates of ROSC (100% vs. 50%), freedom from major adverse events (50% vs. 0% at 48h), and neurologic function (42% with mild or no neurologic deficit and 17% achieving normal function at 48h). CONCLUSIONS: Bundle therapy with a combination of stutter ACD CPR, ITD, sevoflurane, and P188 improved cardiac and neurologic function after 17min of untreated cardiac arrest in pigs. All studies were performed with approval from the Institutional Animal Care Committee of the Minneapolis Medical Research Foundation (protocol #12-11).
OBJECTIVE:Ischemic postconditioning (stutter CPR) and sevoflurane have been shown to mitigate the effects of reperfusion injury in cardiac tissue after 15min of ventricular fibrillation (VF) cardiac arrest. Poloxamer 188 (P188) has also proven beneficial to neuronal and cardiac tissue during reperfusion injury in human and animal models. We hypothesized that the use of stutter CPR, sevoflurane, and P188 combined with standard advanced life support would improve post-resuscitation cardiac and neurologic function after prolonged VF arrest. METHODS: Following 17min of untreated VF, 20 pigs were randomized to Control treatment with active compression/decompression (ACD) CPR and impedance threshold device (ITD) (n=8) or Bundle therapy with stutter ACDCPR+ITD+sevoflurane+P188 (n=12). Epinephrine and post-resuscitation hypothermia were given in both groups per standard protocol. Animals that achieved return of spontaneous circulation (ROSC) were evaluated with echocardiography, biomarkers, and a blinded neurologic assessment with a cerebral performance category score. RESULTS: Bundle therapy improved hemodynamics during resuscitation, reduced need for epinephrine and repeated defibrillation, reduced biomarkers of cardiac injury and end-organ dysfunction, and increased left ventricular ejection fraction compared to Controls. Bundle therapy also improved rates of ROSC (100% vs. 50%), freedom from major adverse events (50% vs. 0% at 48h), and neurologic function (42% with mild or no neurologic deficit and 17% achieving normal function at 48h). CONCLUSIONS: Bundle therapy with a combination of stutter ACDCPR, ITD, sevoflurane, and P188 improved cardiac and neurologic function after 17min of untreated cardiac arrest in pigs. All studies were performed with approval from the Institutional Animal Care Committee of the Minneapolis Medical Research Foundation (protocol #12-11).
Authors: Demetris Yannopoulos; Scott McKnite; Tom P Aufderheide; Gardar Sigurdsson; Ronald G Pirrallo; David Benditt; Keith G Lurie Journal: Resuscitation Date: 2005-03 Impact factor: 5.262
Authors: Eliana Lucchinetti; Sandro Ambrosio; José Aguirre; Patrick Herrmann; Luc Härter; Marius Keel; Thomas Meier; Michael Zaugg Journal: Anesthesiology Date: 2007-02 Impact factor: 7.892
Authors: Soichiro Yasuda; DeWayne Townsend; Daniel E Michele; Elizabeth G Favre; Sharlene M Day; Joseph M Metzger Journal: Nature Date: 2005-07-17 Impact factor: 49.962
Authors: Timothy R Matsuura; Jason A Bartos; Adamantios Tsangaris; Kadambari Chandra Shekar; Matthew D Olson; Matthias L Riess; Martin Bienengraeber; Tom P Aufderheide; Robert W Neumar; Jennifer N Rees; Scott H McKnite; Anna E Dikalova; Sergey I Dikalov; Hunter F Douglas; Demetris Yannopoulos Journal: Resuscitation Date: 2017-04-10 Impact factor: 5.262
Authors: Mihee Kim; Karen J Haman; Evelyne M Houang; Wenjia Zhang; Demetris Yannopoulos; Joseph M Metzger; Frank S Bates; Benjamin J Hackel Journal: Biomacromolecules Date: 2017-06-14 Impact factor: 6.988
Authors: Evelyne M Houang; Karen J Haman; Mihee Kim; Wenjia Zhang; Dawn A Lowe; Yuk Y Sham; Timothy P Lodge; Benjamin J Hackel; Frank S Bates; Joseph M Metzger Journal: Mol Pharm Date: 2017-06-12 Impact factor: 4.939
Authors: Mihee Kim; Milan Vala; Christopher T Ertsgaard; Sang-Hyun Oh; Timothy P Lodge; Frank S Bates; Benjamin J Hackel Journal: Langmuir Date: 2018-06-01 Impact factor: 3.882
Authors: Mihee Kim; Frank Heinrich; Greg Haugstad; Guichuan Yu; Guangcui Yuan; Sushil K Satija; Wenjia Zhang; Hannah S Seo; Joseph M Metzger; Samira M Azarin; Timothy P Lodge; Benjamin J Hackel; Frank S Bates Journal: Langmuir Date: 2020-03-27 Impact factor: 3.882
Authors: Rishabh C Choudhary; Muhammad Shoaib; Samantha Sohnen; Daniel M Rolston; Daniel Jafari; Santiago J Miyara; Kei Hayashida; Ernesto P Molmenti; Junhwan Kim; Lance B Becker Journal: Front Med (Lausanne) Date: 2021-05-18